NCT01054625 2023-08-03Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)GenmabPhase 1/2 Completed31 enrolled 16 charts
NCT00093041 2023-06-28Zalutumumab in Head and Neck CancerGenmabPhase 1/2 Completed28 enrolled 13 charts